Aroa posts $1.5m half year loss but forecasts up to $6m annual profit

Aroa posts $1.5m half year loss but forecasts up to $6m annual profit
Aroa develops, manufactures and distributes medical and surgical products. (Image: Supplied)
John Anthony
Soft tissue regeneration company Aroa Biosurgery has posted a $1.5 million loss for the six months to September but is forecasting annual profit of between $2m and $6m.Founded in 2008, Aroa Biosurgery is headquartered in Auckland and is listed on the Australian Securities Exchange (ASX) with a share price of A65c (NZ72c).The company, which was formerly called Mesynthes, develops, manufactures and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction.ImprovementIts loss for the half year to...

More Markets

Rocket Lab looks to raise up to US$500 million
Markets

Rocket Lab looks to raise up to US$500 million

The money will fund acquisitions and general corporate and working capital purposes.

The who’s who of NZME’s board hopefuls
Markets

The who’s who of NZME’s board hopefuls

Who are the players causing ripples in investor and media circles?

Duke pins recovery hopes on lower interest rates
Retail

Duke pins recovery hopes on lower interest rates

The Briscoe Group chief said he is ‘thrilled to bits’ with the full-year result.

NZSA waves red flags over NZME 'takeover by stealth'
Markets

NZSA waves red flags over NZME 'takeover by stealth'

Billionaire's bid to 'transfer control' of media company raises ire of NZSA.